Gynecology News and Research

RSS

Risk of serious flu-related sickness far outpaces risk of injectable vaccine in pregnant women

Pregnant women who catch the flu are at serious risk for flu-related complications, including death, and that risk far outweighs the risk of possible side effects from injectable vaccines containing killed virus, according to an extensive review of published research and data from previous flu seasons.

30 Oct 2009

Girls' ethnicity and weight linked to participation in risky sexual behaviors

A University of Pittsburgh study sheds new light on the relationship between race, body weight and sexual behavior among adolescent girls. The results suggest that a girl's ethnicity and her actual weight or perception of her weight may play a role in her participation in risky sexual behaviors. The study results are published in the November issue of Pediatrics, now available online.

29 Oct 2009

Interlace Medical receives 510K clearance to market MyoSure Hysteroscopic Tissue Removal System

Interlace Medical, Inc., today announced that it has received 510K clearance from the U. S. Food and Drug Administration (FDA) to market the MyoSure Hysteroscopic Tissue Removal System for the removal of submucosal fibroids and polyps.

28 Oct 2009

Scientific breakthrough to derive human parthenogenetic stem cell lines from unfertilized human eggs

International Stem Cell Corporation (OTCBB:ISCO) (www.internationalstemcell.com) and Reproductive Medicine Associates of New York (RMA of New York) have shown that immature, unfertilized human eggs can be used to create “parthenotes” from which human parthenogenetic stem cell lines may be derived. Immature eggs are normally discarded during standard in vitro fertilization (IVF) procedures due to their inability to create an embryo.

28 Oct 2009

FDA issues clearance for Lumenis' PolyScope Flexible Endoscope

Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, announced that on September 30th, 2009 the FDA issued a 510K to Lumenis stating that the PolyScope Flexible Endoscope can now be sold in the United States.

From Lumenis Inc. 28 Oct 2009

Study: Minimally invasive procedure reduces cost and complications compared to open surgery

Ethicon Endo-Surgery today announced results from two newly published studies that demonstrate a minimally invasive approach in three common procedures resulted in a reduced rate of complications and lower overall cost of care, including a difference of more than $15,000 on average for minimally invasive colectomies, when compared to open surgery.

27 Oct 2009

Cleavage rejuvenation, Botox Breast Lift and Awake-Breast Augmentation - are they safe?

Whether their effectiveness is fact or fiction, less invasive cosmetic procedures such as cleavage rejuvenation, do-it-yourself (DIY) cosmetic therapies, and using Botox- to "lift" the breasts are making headlines, but are they safe? Plastic surgeons will discuss if these, and more, are cutting edge new discoveries or just "buyer beware" marketing hype at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2009 conference, Oct. 23 - 27, in Seattle.

24 Oct 2009

Pregnant women unsure about getting H1N1 flu shot, shows new survey

Despite majorities expressing concern about getting the novel H1N1 (or swine) flu this year, only about one in four pregnant women or new mothers plan to get the H1N1 flu shot, according to findings from a new survey conducted on behalf of HealthyWomen by Harris Interactive.

24 Oct 2009

Obese women retain half of post pregnancy weight

Obese women who gain more than the recommended amount during pregnancy are much more likely to retain a portion of that weight one year after they give birth, according to a Kaiser Permanente study published in the November issue of Obstetrics & Gynecology.

22 Oct 2009

Researchers develop a non-invasive test to help assess embryo viability for IVF

Embryos that are most likely to result in a pregnancy are crucial to the success of in vitro fertilization (IVF) but are difficult to identify. Researchers at Yale School of Medicine, led by Emre Seli, M.D., are developing a fast, non-invasive test to help assess embryo viability for IVF.

22 Oct 2009

New EHR and practice management solution from Nuesoft Technologies

Nuesoft Technologies Inc. today announced the launch of its electronic health record (EHR). The NueMD® EHR 5.2 is certified for Ambulatory EHR 2007 by the Certification Commission for Health Information Technology (CCHIT®), and accompanies NueMD's medical practice management software solution to comprise NueMD® Complete, a fully integrated practice management and electronic medical record.

20 Oct 2009

Women without HOXA13 gene mutation need not be subjected to X-rays

Hugh S. Taylor, M.D., professor in the Department of Obstetrics, Gynecology & Reproductive Sciences at Yale, and colleagues have found that women without mutations of the HOXA13 gene do not need to be subjected to x-rays and other tests for a rare condition called hand-foot genital syndrome. The research is presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia, October 17-21.

20 Oct 2009

Link between stress reduction and increase in pregancy rate established

Women who participated in a stress management program prior to or during their second IVF cycle had a 160 percent greater pregnancy rate than women who did not participate in a program, according to a study presented today at the American Society for Reproductive Medicine's 65th Annual Meeting.

20 Oct 2009

Right combination of estrogen and SERM can reduce breast cancer risk

The right combination of estrogen and a selective estrogen receptor modulator (SERM), which blocks the effects of estrogen in breast tissue, could relieve menopause symptoms and cut breast cancer risk, Yale researchers report in an abstract presented at the American Society for Reproductive Medicine (ASRM) scientific meeting in Atlanta, Georgia, October 17-21.

20 Oct 2009

GlaxoSmithKline receives FDA approval for cervical cancer vaccine

GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10-25).

19 Oct 2009

Depression becomes more difficult to treat the longer it goes undiagnosed or undertreated

A new survey of 2,001 adults living with depression revealed that despite being diagnosed for an average of 12 years, many unknowingly took actions that could have sabotaged their chances of getting well. Furthermore, on average, it took about six years for respondents to seek diagnosis from a health care professional, suggesting these adults may have been coping with depression for as long as 18 years.

15 Oct 2009

Researchers develop magneto-nano sensor chip to detect cancer

Searching for biomarkers that can warn of diseases such as cancer while they are still in their earliest stage is likely to become far easier thanks to an innovative biosensor chip developed by Stanford University researchers.

14 Oct 2009

Ethicon Endo-Surgery launches energy delivery devices at the 95th ACS Annual Clinical Congress

Ethicon Endo-Surgery, Inc., today unveiled its broad portfolio of energy delivery devices at the 95th Annual Clinical Congress of the American College of Surgeons (ACS).

12 Oct 2009

New soy germ-based ingredient improves menopausal symptoms

SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women.

9 Oct 2009

More than 2m infants, women die from childbirth annually, study says

Each year, more than 2 million infants and women around the world die from childbirth-related complications, according to a study released Tuesday at the International Federation of Gynecology and Obstetrics world congress in Cape Town, South Africa, the Associated Press reports.

8 Oct 2009

Gynecology News and Research

Risk of serious flu-related sickness far outpaces risk of injectable vaccine in pregnant women

Girls' ethnicity and weight linked to participation in risky sexual behaviors

Interlace Medical receives 510K clearance to market MyoSure Hysteroscopic Tissue Removal System

Scientific breakthrough to derive human parthenogenetic stem cell lines from unfertilized human eggs

FDA issues clearance for Lumenis' PolyScope Flexible Endoscope

Study: Minimally invasive procedure reduces cost and complications compared to open surgery

Cleavage rejuvenation, Botox Breast Lift and Awake-Breast Augmentation - are they safe?

Pregnant women unsure about getting H1N1 flu shot, shows new survey

Obese women retain half of post pregnancy weight

Researchers develop a non-invasive test to help assess embryo viability for IVF

New EHR and practice management solution from Nuesoft Technologies

Women without HOXA13 gene mutation need not be subjected to X-rays

Link between stress reduction and increase in pregancy rate established

Right combination of estrogen and SERM can reduce breast cancer risk

GlaxoSmithKline receives FDA approval for cervical cancer vaccine

Depression becomes more difficult to treat the longer it goes undiagnosed or undertreated

Researchers develop magneto-nano sensor chip to detect cancer

Ethicon Endo-Surgery launches energy delivery devices at the 95th ACS Annual Clinical Congress

New soy germ-based ingredient improves menopausal symptoms

More than 2m infants, women die from childbirth annually, study says

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News